RenovoRx chairman and CMO Ramtin Agah reports $46,485 share purchase
RNXT•Ramtin Agah purchased 50,000 RenovoRx common shares at $0.9297 each, bringing his direct beneficial ownership to 848,460 shares.
RNXT•Ramtin Agah purchased 50,000 RenovoRx common shares at $0.9297 each, bringing his direct beneficial ownership to 848,460 shares.
RenovoRx Executive Chairman and Chief Medical Officer Ramtin Agah purchased 50,000 common shares at $0.9297 per share. The purchase brought his direct beneficial ownership to 848,460 shares.